Ca-AKG study record: results pending.
A randomized, quadruple-masked, placebo-controlled study is evaluating Ca-AKG over 12 weeks, with change in PhenoAge as its primary outcome. No results are posted.
- Planned participants
- 30
- Study dose
- 2 g/day
- Duration
- 12 weeks
- Status
- Results not yet posted

